心臟病除顫器設備銷售市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、最終用戶、地區和競爭細分，2019-2029 年

2023 年全球心臟去顫器設備銷售市場價值為99.2 億美元，預計到2029 年將在預測期內穩定成長，複合年成長率為5.25%。產業的關鍵部分，在解決危及生命的心律不整方面發揮關鍵作用。多年來，除顫器已經取得了顯著的發展，已成為緊急醫療環境、醫院和救護車中不可或缺的設備。在人們對心血管疾病的認知不斷提高、技術進步以及全球人口老化的推動下，心臟病除顫器設備銷售市場正在強勁成長。除顫器是一種醫療設備，旨在向心臟提供電擊，在心臟驟停或其他危及生命的心律不整期間恢復正常心律。

市場概況
預測期	2025-2029
2023 年市場規模	99.2億美元
2029 年市場規模	135.2億美元
2024-2029 年複合年成長率	5.25%
成長最快的細分市場	植入式心臟復律去顫器 (ICD)
最大的市場	北美洲

由於久坐的生活方式、不良的飲食習慣和人口老化，全世界心血管疾病的盛行率不斷上升。這大大增加了對心臟病除顫器設備的需求，因為它們對於預防和緊急干預至關重要。心臟病除顫器設備領域的持續技術進步正在提高其功效和安全性。智慧技術的整合、更長的電池壽命和方便用戶使用的介面是促進市場成長的一些創新。全球各國政府和醫療機構越來越認知到改善緊急應變系統的重要性。對公共除顫 (PAD) 計劃的投資以及提高 CPR（心肺復甦術）意識的舉措正在推動市場成長。

主要市場促進因素

心血管疾病發生率上升正在推動全球心臟病除顫器設備銷售市場

不斷提高的意識和培訓計劃正在推動全球心臟病除顫器設備銷售市場

主要市場挑戰

設備成本高

主要市場趨勢

技術進步

細分市場洞察

產品洞察

最終使用者見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球心臟病除顫器設備銷售市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品（植入式心臟復律去顫器 (ICD)、體外去顫器、穿戴式式心臟復律去顫器 (WCDS)、高級生命維持裝置等）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按地區
  • 按公司分類 (2022)
• 市場地圖
  • 按產品分類
  • 按最終用戶
  • 按地區

第 5 章：亞太地區心臟病除顫器設備銷售市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 6 章：歐洲心臟病除顫器設備銷售市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 7 章：北美心臟病除顫器設備銷售市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 8 章：南美洲心臟病除顫器設備銷售市場前景

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 9 章：中東和非洲心臟病除顫器設備銷售市場前景

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：市場動態

• 促進要素
• 挑戰

第 11 章：市場趨勢與發展

• 最近的發展
• 產品發布
• 併購

第 12 章：全球心臟病去顫器設備銷售市場：SWOT 分析

第 13 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第14章：競爭格局

• ST. Jude Medical, Inc.
• Heartsine Technologies, Inc.
• Zoll Medical Corporation
• Medical Research Laboratories, Inc.
• Sorin Group
• Boston Scientific Corporation
• Physio-Control, Inc.
• Laerdal Medical Corporation
• Cardiac Science Corporation
• Medtronic Physio-Control Corporation
• Koninklijke Philips NV,
• Nihon Kohden Corporation
• Cardiac Science, Inc.
• Stryker Corporation

第 15 章：策略建議

第16章調查會社について,免責事項

Global Cardiology Defibrillators Devices Sales Market was valued at USD 9.92 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. The global cardiology defibrillators devices sales market is a critical segment within the broader healthcare industry, playing a pivotal role in addressing life-threatening cardiac arrhythmias. Defibrillators have evolved significantly over the years, becoming indispensable devices in emergency medical settings, hospitals, and ambulances. The cardiology defibrillators devices sales market is witnessing robust growth driven by increasing awareness of cardiovascular diseases, advancements in technology, and a rising aging population globally. Defibrillators are medical devices designed to deliver an electric shock to the heart, restoring normal heart rhythm during sudden cardiac arrest or other life-threatening arrhythmias.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 9.92 Billion
Market Size 2029	USD 13.52 Billion
CAGR 2024-2029	5.25%
Fastest Growing Segment	Implantable Cardioverter Defibrillator (ICDs)
Largest Market	North America

The prevalence of cardiovascular diseases is escalating worldwide, attributed to sedentary lifestyles, poor dietary habits, and an aging population. This has significantly increased the demand for cardiology defibrillators devices, as they are essential for both prevention and emergency interventions. Ongoing technological advancements in the field of cardiology defibrillators devices are enhancing their efficacy and safety. Integration of smart technologies, improved battery life, and user-friendly interfaces are some of the innovations contributing to the market's growth. Governments and healthcare organizations globally are increasingly recognizing the importance of improving emergency response systems. Investments in public access defibrillation (PAD) programs and initiatives to raise awareness about CPR (Cardiopulmonary Resuscitation) are propelling market growth.

Key Market Drivers

Rising Incidence of Cardiovascular Diseases is Driving the Global Cardiology Defibrillators Devices Sales Market

Cardiovascular diseases (CVDs) remain a significant global health challenge, contributing to a substantial number of deaths worldwide. As the prevalence of CVDs continues to rise, the demand for advanced medical devices, such as cardiology defibrillators, has increased exponentially. This surge in demand is a direct response to the urgent need for effective interventions to address the rising incidence of heart-related ailments. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and sudden cardiac arrest. The World Health Organization (WHO) identifies CVDs as the leading cause of death globally, accounting for an estimated 17.9 million deaths annually. Unhealthy lifestyle choices, such as poor diet, lack of physical activity, and smoking, alongside increasing age and genetic predisposition, contribute to the growing burden of CVDs.

The global rise in life expectancy and aging populations is a significant driver behind the increasing prevalence of cardiovascular diseases. With age, individuals are more susceptible to developing conditions such as hypertension, atherosclerosis, and heart failure. Additionally, lifestyle factors, including sedentary behaviour, unhealthy diets, and stress, contribute to the escalating incidence of heart-related ailments. Urbanization and industrialization have brought about profound changes in people's lifestyles, contributing to the global epidemic of cardiovascular diseases. Urban environments often promote unhealthy habits such as a lack of physical activity, higher stress levels, and the consumption of processed foods. These factors, coupled with increased exposure to environmental pollutants, create a conducive environment for the development of cardiovascular diseases.

Cardiology defibrillators play a crucial role in the management of cardiovascular diseases, particularly in cases of sudden cardiac arrest (SCA). Sudden cardiac arrest occurs when the heart suddenly stops beating, leading to a cessation of blood flow to vital organs. Prompt intervention with a defibrillator, which delivers an electric shock to the heart, can restore a normal heartbeat and improve the chances of survival. As awareness of the life-saving potential of defibrillators grows, there has been a significant uptick in their adoption in various healthcare settings, including hospitals, clinics, and public spaces. Automated External Defibrillators (AEDs) are increasingly becoming more accessible in public places, providing individuals with the means to respond quickly to cardiac emergencies before professional medical assistance arrives. The escalating demand for cardiology defibrillators has fueled significant growth in the global market. Technological advancements have played a crucial role in the development of more sophisticated and user-friendly defibrillator devices. Integration of artificial intelligence, portable designs, and enhanced connectivity features are some of the key innovations that have enhanced the effectiveness and accessibility of these life-saving devices. Moreover, an increasing focus on public awareness campaigns and training initiatives for CPR (Cardiopulmonary Resuscitation) and AED use has contributed to a more informed and responsive general population. Governments and healthcare organizations are recognizing the importance of creating heart-safe environments by strategically placing AEDs in public spaces and ensuring that individuals are trained to use them effectively.

Growing Awareness and Training Initiatives is Driving the Global Cardiology Defibrillators Devices Sales Market

The field of cardiology has witnessed remarkable advancements in recent years, and one of the critical areas that has seen substantial growth is the market for cardiology defibrillator devices. These life-saving devices play a pivotal role in the management of cardiac arrhythmias and sudden cardiac arrest, making them indispensable in the realm of emergency cardiac care. The global cardiology defibrillators devices sales market is currently experiencing an upsurge, primarily attributed to the growing awareness about cardiovascular health and the implementation of extensive training initiatives worldwide. Public awareness campaigns and educational initiatives have played a crucial role in disseminating information about the importance of early defibrillation. Government health agencies, non-profit organizations, and healthcare providers are actively engaged in raising awareness about the signs of cardiac arrest, the need for immediate action, and the availability of automated external defibrillators (AEDs) in public spaces. This heightened awareness has not only increased the demand for AEDs but has also driven sales in the broader cardiology defibrillators devices market.

Alongside awareness campaigns, the emphasis on training initiatives has become pivotal in ensuring that individuals are equipped to respond effectively in emergency situations. Training programs in cardiopulmonary resuscitation (CPR) and AED usage have been implemented globally, empowering both healthcare professionals and the general public to administer life-saving interventions. This proactive approach has not only saved lives but has also contributed to the surge in demand for defibrillator devices.

Key Market Challenges

High Cost of Devices

While the demand for defibrillators continues to grow, the high cost of these devices presents a formidable obstacle. The complex engineering, sophisticated technology, and stringent regulatory requirements contribute to the elevated production costs, which are then transferred to the end-users. Hospitals, clinics, and emergency response units often find it challenging to allocate substantial budgets for acquiring defibrillators, limiting their ability to deploy these devices on a large scale. The high cost of defibrillators directly affects their accessibility in both developed and developing regions. In low-income countries, where healthcare budgets are already strained, the prohibitive prices of these devices create a stark disparity in access to life-saving interventions. Even in wealthier nations, budget constraints within healthcare systems can limit the widespread deployment of defibrillators, potentially impacting patient outcomes during cardiac emergencies.

Efforts are underway to address the high cost challenge and make defibrillators more accessible globally. Collaborations between industry stakeholders, governments, and non-profit organizations are crucial for developing strategies to reduce production costs without compromising on the quality and effectiveness of these devices. Research and development initiatives that focus on creating more cost-efficient technologies and manufacturing processes are essential for driving down overall prices. Government intervention through policies and incentives can play a pivotal role in promoting affordability and accessibility. Subsidies, tax breaks, and grants for healthcare institutions looking to invest in defibrillators can encourage widespread adoption. Governments can also collaborate with manufacturers to explore innovative financing models, such as lease programs or bulk purchasing agreements, to make defibrillators more economically viable for healthcare providers.

Key Market Trends

Technological Advancements

The field of cardiology is witnessing a revolutionary transformation propelled by rapid technological advancements, particularly in the domain of defibrillator devices. Defibrillators play a pivotal role in the management of cardiac arrhythmias and sudden cardiac arrest, and the market for these life-saving devices is experiencing unprecedented growth. Recent years have seen a significant integration of AI and ML technologies in the healthcare sector, and cardiology is no exception. Defibrillator devices are becoming smarter with the incorporation of advanced algorithms that can analyze patient data in real-time. AI-powered defibrillators can provide more accurate diagnostics, personalized treatment plans, and even predict potential cardiac events, enhancing the overall efficacy of the devices.

Technological advancements have led to the miniaturization of defibrillator devices, making them more portable and convenient for patients. Wearable defibrillators, in particular, have gained prominence, allowing individuals at risk of sudden cardiac arrest to carry a compact device that continuously monitors their heart rhythm. This trend not only promotes patient compliance but also ensures immediate intervention in case of any abnormalities. The integration of telemedicine and remote monitoring capabilities in defibrillator devices is another driving force in the market. Patients can now be remotely monitored by healthcare professionals, providing real-time data on their cardiac health. This facilitates early detection of issues, timely interventions, and reduces the need for frequent hospital visits. The global COVID-19 pandemic has further accelerated the adoption of remote monitoring solutions. Electrode technologies have undergone significant improvements, contributing to the enhanced performance of defibrillator devices. Novel electrode materials and designs ensure better contact with the patient's skin, leading to improved signal quality and accuracy. This results in more precise delivery of therapeutic shocks and reduces the risk of unnecessary interventions.

Modern defibrillator devices are increasingly equipped with enhanced data connectivity and interoperability features. Seamless integration with electronic health records (EHRs) and other healthcare systems allows for efficient data sharing and communication between different healthcare providers. This interconnected ecosystem fosters collaborative care, ensuring that patients receive the most comprehensive and coordinated treatment. Advances in genomics and molecular biology have paved the way for personalized medicine in cardiology. Defibrillator devices can now be tailored to an individual's genetic makeup, allowing for more targeted and effective treatments. This personalized approach improves patient outcomes and reduces the likelihood of adverse reactions to therapies.

Segmental Insights

Product Insights

Based on the category of Product, Implantable Cardioverter Defibrillator (ICDs) emerged as the dominant player in the global market for Cardiology Defibrillators Devices Sales in 2023. ICDs are sophisticated electronic devices designed to monitor and regulate abnormal heart rhythms, specifically ventricular tachycardia and ventricular fibrillation. These conditions can lead to sudden cardiac arrest, a medical emergency with potentially fatal consequences. ICDs are implanted subcutaneously or intravenously and continuously monitor the heart's rhythm, delivering electrical shocks when necessary to restore a normal heartbeat.

ICDs are highly effective in managing life-threatening arrhythmias. By continuously monitoring the heart's electrical activity, these devices can promptly detect abnormal rhythms and deliver therapeutic shocks to restore normalcy. This capability has proven to be crucial in preventing sudden cardiac death in high-risk patients. Continuous research and development in the field of cardiology have led to significant technological advancements in ICDs. Modern devices are equipped with sophisticated algorithms, remote monitoring capabilities, and programmable settings, enhancing their overall efficacy. These advancements have increased the acceptance and adoption of ICDs among healthcare professionals and patients alike. The global prevalence of cardiovascular diseases, including arrhythmias, has been on the rise. Factors such as sedentary lifestyles, poor dietary habits, and an aging population contribute to the increasing burden of cardiac conditions. As a result, there is a growing need for effective and reliable devices like ICDs to manage and mitigate the risks associated with these diseases.

End User Insights

The Hospitals & Clinics segment is projected to experience rapid growth during the forecast period. Hospitals and clinics boast well-established infrastructures, equipped with state-of-the-art facilities and skilled medical professionals. The presence of specialized cardiology units and emergency departments in these healthcare settings enhances their ability to diagnose and treat cardiovascular conditions promptly. This makes hospitals and clinics the natural epicenter for the utilization of cardiology defibrillators devices, as they can provide timely and effective interventions. With a growing emphasis on public awareness and training in basic life support (BLS) and advanced cardiac life support (ACLS), more individuals are becoming familiar with the importance of defibrillation in saving lives during cardiac emergencies. Hospitals and clinics, being primary hubs for medical education and training, contribute significantly to the dissemination of knowledge regarding the proper use of defibrillators. This heightened awareness further fuels the demand for these life-saving devices.

Regional Insights

North America emerged as the dominant player in the global Cardiology Defibrillators Devices Sales market in 2023, holding the largest market share in terms of value. North America has been at the forefront of technological innovation in the field of healthcare, and cardiology is no exception. Continuous investment in research and development has led to the creation of cutting-edge defibrillator devices that are more effective, efficient, and user-friendly. Advanced technologies such as implantable cardioverter-defibrillators (ICDs), wearable defibrillators, and automated external defibrillators (AEDs) have become standard components of cardiac care, contributing significantly to the region's dominant market position. The prevalence of cardiovascular diseases (CVDs) in North America is a key driver of the demand for cardiology defibrillators. Lifestyle factors, genetic predisposition, and an aging population contribute to the high incidence of conditions such as sudden cardiac arrest (SCA) and ventricular fibrillation. As a result, there is a growing need for defibrillation devices to effectively manage and respond to cardiac emergencies.

Key Market Players

ST. Jude Medical, Inc.

Heartsine Technologies, Inc.

Zoll Medical Corporation

Medical Research Laboratories, Inc.

Sorin Group

Boston Scientific Corporation

Physio-Control, Inc.

Laerdal Medical Corporation

Cardiac Science Corporation

Medtronic Physio-Control Corporation

Koninklijke Philips N.V.,

Nihon Kohden Corporation

Cardiac Science, Inc.

Stryker Corporation

Report Scope:

In this report, the Global Cardiology Defibrillators Devices Sales Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiology Defibrillators Devices Sales Market, By Product:

Implantable Cardioverter Defibrillator (ICDs) External Defibrillator Wearable Cardioverter Defibrillator (WCDS) Advanced Life Support Units Others

Cardiology Defibrillators Devices Sales Market, By End User:

Hospitals & Clinics Ambulatory Care Centers Others

Cardiology Defibrillators Devices Sales Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Cardiology Defibrillators Devices Sales Market.

Available Customizations:

Global Cardiology Defibrillators Devices Sales market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Cardiology Defibrillators Devices Sales Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Implantable Cardioverter Defibrillator (ICDs), External Defibrillator, Wearable Cardioverter Defibrillator (WCDS), Advanced Life Support Units, Others)
  • 4.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2022)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By End User
  • 4.3.3. By Region

5. Asia Pacific Cardiology Defibrillators Devices Sales Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By End User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By End User
  • 5.3.2. India Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By End User
  • 5.3.3. Australia Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By End User
  • 5.3.4. Japan Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By End User
  • 5.3.5. South Korea Cardiology Defibrillators Devices Sales Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By End User

6. Europe Cardiology Defibrillators Devices Sales Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End User
  • 6.3.2. Germany Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End User
  • 6.3.3. Spain Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End User
  • 6.3.4. Italy Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By End User
  • 6.3.5. United Kingdom Cardiology Defibrillators Devices Sales Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By End User

7. North America Cardiology Defibrillators Devices Sales Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End User
  • 7.3.2. Mexico Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End User
  • 7.3.3. Canada Cardiology Defibrillators Devices Sales Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End User

8. South America Cardiology Defibrillators Devices Sales Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End User
  • 8.3.2. Argentina Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End User
  • 8.3.3. Colombia Cardiology Defibrillators Devices Sales Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End User

9. Middle East and Africa Cardiology Defibrillators Devices Sales Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End User
  • 9.3.2. Saudi Arabia Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End User
  • 9.3.3. UAE Cardiology Defibrillators Devices Sales Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Cardiology Defibrillators Devices Sales Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. ST. Jude Medical, Inc.
  • 14.1.1. Company Snapshot
  • 14.1.2. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Heartsine Technologies, Inc.
• 14.3. Zoll Medical Corporation
• 14.4. Medical Research Laboratories, Inc.
• 14.5. Sorin Group
• 14.6. Boston Scientific Corporation
• 14.7. Physio-Control, Inc.
• 14.8. Laerdal Medical Corporation
• 14.9. Cardiac Science Corporation
• 14.10.Medtronic Physio-Control Corporation
• 14.11.Koninklijke Philips N.V.,
• 14.12.Nihon Kohden Corporation
• 14.13.Cardiac Science, Inc.
• 14.14.Stryker Corporation

15. Strategic Recommendations

16. About Us & Disclaimer